Esomeprazole and Risedronate Interaction
Drug interaction information between Esomeprazole and Risedronate.
Esomeprazole and Risedronate have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Esomeprazole and Risedronate. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
This acid-reducing medicine can cause your body to absorb a larger amount of the bone medication than it normally would.
What To Do
Your doctor may need to monitor you more closely for side effects since more of the drug is entering your system.
FDA Label Information
Co-administration of risedronate sodium with the PPI, esomeprazole, increased risedronate bioavailability.
Esomeprazole Also Interacts With
- Posaconazole major
- Clopidogrel moderate
- Digoxin minor
Frequently Asked Questions
Can I take Esomeprazole and Risedronate together?
This is a minor interaction. Your doctor may need to monitor you more closely for side effects since more of the drug is entering your system.
How serious is the interaction between Esomeprazole and Risedronate?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Esomeprazole and Risedronate interact?
This acid-reducing medicine can cause your body to absorb a larger amount of the bone medication than it normally would.
Understanding the Esomeprazole and Risedronate Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Esomeprazole belongs to the Proton Pump Inhibitor (PPI) class and Risedronate belongs to the Bisphosphonate class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: This acid-reducing medicine can cause your body to absorb a larger amount of the bone medication than it normally would. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Esomeprazole has 4 total documented interactions on file in this dataset, and Risedronate has 2. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to monitor you more closely for side effects since more of the drug is entering your system. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Esomeprazole or Risedronate based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.